EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Virtual reality therapy is a feasible and tolerable adjunct to ketamine treatment for PTSD and depression

Safa Rubaye, Aditya Shah, Waleed Aldulaimy, Ashley Hernandez

Discover Mental Health · 27.10.2026

DOI: 10.1007/s44192-026-00643-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Mental Health, online erschienen am 27.10.2026. Verfasst von Safa Rubaye und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine is an important intervention for severe depression and trauma-related psychopathology, but the optimal way to provide therapeutic support during treatment remains unclear. Although ketamine-assisted psychotherapy is clinically appealing, maintaining therapist presence throughout every dosing session can be logistically difficult. Virtual reality (VR) may offer a structured, scalable, therapist-sparing adjunct delivered during ketamine sessions while preserving a therapeutic frame. This retrospective chart review evaluated the feasibility and tolerability of adjunct VR during ketamine treatment and examined exploratory clinical outcomes relative to treatment without VR. Patients were included if they received a ketamine treatment course with or without VR and had both baseline and post-treatment symptom assessments. Of 69 patients with a documented ketamine course, 28 met this requirement and formed the analytic cohort: 19 treated with VR and 9 without VR. Primary outcomes were feasibility and tolerability, assessed using treatment-course burden and chart-documented adverse effects, with vital signs monitored during each session. Secondary outcomes were changes in PHQ-9, GAD-7, PCL-5, and PSS scores from baseline to follow-up. Within-group change was tested with Wilcoxon signed-rank tests, and between-group comparisons used Mann-Whitney U tests. Adjunct VR was associated with low rates of adverse effects and a treatment course length comparable to the no-VR group. Within the VR cohort, significant improvement was observed across all symptom measures. Between-group analyses did not show significant differences after correction for multiple testing. These findings suggest that VR is a feasible and tolerable adjunct to ketamine treatment, with clinical outcomes broadly comparable to treatment without VR. Not applicable.

Zitieren

APA

Rubaye, S., Shah, A., Aldulaimy, W., & Hernandez, A. (2026). Virtual reality therapy is a feasible and tolerable adjunct to ketamine treatment for PTSD and depression. Discover Mental Health. https://doi.org/10.1007/s44192-026-00643-w

Vancouver

Rubaye S, Shah A, Aldulaimy W, Hernandez A. Virtual reality therapy is a feasible and tolerable adjunct to ketamine treatment for PTSD and depression. Discover Mental Health. 2026. doi:10.1007/s44192-026-00643-w

BibTeX
@article{Rubaye2026,
  author = {Rubaye, Safa and Shah, Aditya and Aldulaimy, Waleed and Hernandez, Ashley},
  title = {Virtual reality therapy is a feasible and tolerable adjunct to ketamine treatment for PTSD and depression},
  journal = {Discover Mental Health},
  year = {2026},
  doi = {10.1007/s44192-026-00643-w}
}
Kostenlos starten →